The miniature IPSCs (mIPSCs) were recorded in the voltage-clamp mode at a holding potential of −65 mV using a high chloride intracellular solution, containing 105 mM KCl instead of K-gluconate. To block AP triggered release, 0.5 μm tetrodotoxin was added to the aCSF. DNQX, AP-5, and CGP55845 were added to the aCSF to antagonize AMPA-, NMDA-, and GABAB receptor-mediated currents, respectively, and to record pharmacologically isolated GABAAR-mediated mIPSCs. Neurons were allowed to equilibrate for at least 5 min prior to recordings. Frequency, amplitudes and kinetics of mIPSCs, rise time10–90% and decay time90–10%, were automatically analyzed during baseline conditions and in presence of DynA using Clampfit10.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.